M. Murawsky, MD | Authors

MNM Activities

73-1317 Hiolani St

Kailua Kona



Docetaxel vs Mitomycin Plus Vinblastine in Anthracycline-Resistant Metastatic Breast Cancer

August 01, 1997

This nonblinded, multicenter, randomized phase III study compares the median time to progression (primary endpoint), response rate, and quality of life, safety, and survival of